Cream Cream Trozimed Davipharm Treatment of light and medium psoriasis (30g)
Dosage form Tube
Specifications Calcipotriol
Ingredient
Thành phần cho 1g
| Composition information | Content |
| Calcipotriol | 50mcg |
Uses
Indications
Trozimed drugs are indicated in the following cases:
pharmacokinetics
After applying to the scalp of Calcipotriol solution 0.005% to healthy skin or psoriasis patches, less than 1% of the dose is absorbed through the skin for 12 hours. If applying 0.005% ointment, about 5-6% of the drug is absorbed into the body for 12 hours. Absorb through the skin of the topical cream has not been studied. Most of the absorption drugs are converted into non -activity metabolites within 24 hours in the liver and excreted through bile.
Before taking Cream Cream Trozimed Davipharm Treatment of light and medium psoriasis (30g)
How to use
Use topical skin. A thin layer of ointment should be applied to the skin and rub gently to cover all the affected skin until the drug is absorbed.
Dosage
Adults
Use alone
Apply trozimed to the sick skin in the limbs or body 1 or 2 times/day. Recommended use 2 times/day (morning and evening) at the beginning of treatment, may be reduced once a day when switching to maintained treatment, depending on the response.
The maximum amount of ointment is not more than 100g per week. If the drug is used with cream or solution containing other calcifications, the doses of calcificationriol total a total of a week must not exceed 5mg.
Treatment time is based on clinical manifestations. The drug has a clear treatment effect after a maximum of 4 - 8 weeks. Treatment may be repeated.
Used in combination
Use 1 time/day in combination with corticosteroids for external use (for example, using trozimed in the morning and steroids in the evening) is effective and well tolerated.
Special subjects
Patients with liver kidney failure
Do not treat calcificationriol for patients with kidney failure or severe liver failure.
Children and teenagers (under 18 years old)
Experience in using Calcipotriol ointment in children and adolescents is limited. Effective and safe when using the above adult dose mentioned above has not been established in children and adolescents. Therefore, it is not recommended to use in this object group.
Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.
What to do when overdose?
Symptoms
Use an overdose drug that can cause hypercalcemia but will quickly recover after stopping the drug. Clinical signs of hypercalcemia include: anorexia, nausea, vomiting, constipation, reducing muscle tone, depression, coma and unconsciousness.
Handling
If the patient has hypercalcemia due to topicals, it is necessary to stop treatment until this index returns to normal.
What to do when you forget 1 dose? If you have any more questions, ask your doctor or pharmacist.
Side Effects
When using trozimed drugs, you may experience unwanted effects (ADR).
According to clinical information, about 25% of patients treated with calcableriol may have unwanted effects, usually mild. The most commonly reported effect is the diverse transient skin reactions, especially irritating in the location of the lesion/around the injury position.
Unwanted effects by frequency and organ system:
Very common, ADR ≥ 1/10
Common, 1/100 ≤ ADR
Skin and subcutaneous tissues: itching, skin burns, skin stinging, dry skin, roses, rash (including roses, papules, pustules and water gloss).
Uncommon, 1/1,000 ≤ ADR
Very rare, ADR
Instructions on how to handle ADR
The drug may have other unwanted effects, advising the patient to notify the doctor unwanted effects when taking the drug.
Warnings
Before using the drug you need to read the instructions carefully and refer to the information below.
Contraindicated
Trozimed drugs contraindicated in the following cases:
Prisable when using
recommend that patients wash their hands after applying the drug and avoid unintentionally adhere to other parts of the body, especially on the face. Only external, not using eye, drinking or in the vagina.
Advise patients to not use more than a week of a week because of hypoglycemia, quickly recover when stopping treatment.
The risk of hypercalcemia is at least when complying with the recommended dose.
Be careful in patients with other psoriasis, because there is a report on hypercalcemia in patients with psoriasis with pustules or psoriasis with red skin flaky.
Because the effect may occur on calcium metabolism, it is recommended that patients must not overdose recommended and do not add substances to increase the ability to penetrate (such as salicylic acid) as well as substances that prevent penetration.
Clinical symptoms of blood calcium hypercalcemia may be similar to the symptoms of cholecalciferol overdose, such as blood calcium hypercactive syndrome or calcium poisoning, based on the level and time of hypercalcemia. Hypered with persistent blood calcium can lead to accumulation of calcium on the wall of the uterus, joints, stomach, cornea and renal parenchyma.
It is recommended that patients avoid or limit skin exposure in natural or artificial sunlight. Only use Calcipotriol used skin with UV emission when the doctor and the patient consider the benefits that are superior to the risk.
Patients with severe renal impairment or liver failure should not be treated with Calcipotriol because of the limited clinical experience.
Avoid or limit to expose the drug with natural light or light, or optical treatment.
The drug contains propylene glycol can cause skin irritation, polysorbat 80 can cause allergies.
Children
Effective and safe when used for a long time the adult dose mentioned above has not been set in children and teenagers. Therefore, it is not recommended to use in this group of objects.
The ability to drive and operate machinery
Calcipotriol has no effect or negligible effect on the ability to drive and operate machinery.
Pregnancy
Safety when using calcipotriol during pregnancy in humans has not been set. Calcipotriol has passed the placenta, but there is no controlled, adequate studies in pregnant women. Animal research shows that toxicity on fertility when taking orally oral calcable. Calcipotriol used skin is absorbed a little into the body but is not thought to change the balance of the lip bali. It is better to avoid using Calcipotriol during pregnancy.
Breastfeeding period
It is unclear whether Calcipotriol has secretion into breast milk. Calcipotriol distribution in the body is predicted similar to other vitamins. Using calcipotriol in a short time on a small surface does not lead to body absorption and has not seen an impact on breastfed babies. In other cases, breastfeeding is not recommended while using calcipotriol.
Medicinal interaction
When using trozimed simultaneously with ultraviolet light treatment B, it is necessary to apply drugs for at least 2 hours before or after ultraviolet rays to avoid reducing the effects of ultraviolet rays as well as calcipotriol.
Simultaneous use of calcification and salicylic acid -use acid that can lead to loss of effect of calcableriol.
No experience in coordination with other psoriasis drugs on the same skin area at the same time.
Storage
Keep the drug in the original packaging of the manufacturer, covered.
Put the drug in a dry place, avoid light, the temperature is not more than 25 ° C, avoid freezing and out of the reach of children.
Do not use the drug after the expiry date indicated on the packaging (box and blister box).
Other drugs
- CETRABEN EMOLLIENT CREAM
- FLARIN 200 MG SOFT CAPSULES
- LEDERMIX FOR DENTAL USE
- MIFEGYNE 200 MG TABLETS
- OTOMIZE EAR SPRAY
- Silodyx
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions